000			02056cam a2200349 a 4500
003			EG-GiCUC
005			20250223031054.0
008			141014s2014 ua f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.28.M.Sc.2014.Ay.C
100	0		_aAya Zeiada Mohamed
245	1	2	_aA comparative randomized study of safety and efficacy of once versus twice daily dose of amikacin in treatment of neonatal sepsis / _cAya Zeiada Mohamed ; Supervised Heba Hany Abu Hussein , Dalia Ahmed Khairy , Rania Ahmed Zayed
246	1	5	_aدراسة مقارنة عشوائية لمدى فاعلية و أمان عقار الأميكيسين كجرعة واحدة أو مزدوجة فى علاج التسمم البكتيرى لدى حديثى الولادة
260			_aCairo : _bAya Zeiada Mohamed , _c2014
300			_a97 P. ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics
520			_aNeonates frequently receive amikacin as empiric therapy for severe infections caused by suspected Gram - negative bacteria. Optimum dosing of amikacin is required because of the inter - individual variability in the pharmacokinetics in the neonatal population. This study was conducted to compare the efficacy and safety (nephrotoxicity) of once daily versus twice daily dosing of amikacin in suspected or proven sepsis in neonates in relation to the pharmacokinetics of the drug as well as amikacin pharmacokinetic parameters determination under these two dosing schedules in the septic neonates of the Egyptian population
530			_aIssued also as CD
653		4	_aAmikacin
653		4	_aAminoglycosides
653		4	_aNeonatal sepsis
700	0		_aDalia Ahmed Khairy , _eSupervisor
700	0		_aHeba Hany Abu Hussein , _eSupervisor
700	0		_aRania Ahmed Zayed , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c47782 _d47782